Becton, Dickinson and Company (BD) has introduced a new needle-free blood draw technology in the US in the form of the PIVO Pro Needle-free Blood Collection Device, which is designed to be compatible with integrated catheters.

The device, which has received 510(k) clearance from the US Food and Drug Administration (FDA), includes design enhancements that make it the first and only option for use with integrated and extended peripheral IV catheters, said the company.

This compatibility extends to the new Nexiva Closed IV Catheter System with NearPort IV Access, building upon the existing PIVO compatibility with traditional short peripheral IV catheters established since 2017.

According to BD, the PIVO Pro Needle-free Blood Collection Device merges the clinical advantages demonstrated by the integrated closed Nexiva Catheter System. These include extended dwell times and fewer catheter-related issues, with the capability to collect high-quality blood samples directly from a patient’s peripheral IV line using PIVO Pro.

The device therefore significantly reduces the requirement for additional needle insertions.

BD medication delivery solutions worldwide president Eric Borin said: “The latest innovation to our PIVO portfolio helps expand needle-free blood collection to even more patients and clinicians as we continue to redefine the standard of care through our ‘One-Stick Hospital Stay’ vision.

“This new solution helps to reduce unnecessary and repeat needlesticks in the hospital while elevating clinical outcomes, improving workflow and creating a better experience for clinicians and patients.”

The pairing of PIVO Pro with Nexiva featuring NearPort IV Access is designed to access ideal conditions for blood draws, thereby enhancing both clinician efficiency and the overall patient experience.

This approach to drawing blood samples has been demonstrated to optimise IV performance, minimise sample errors that may necessitate redraws and cause delays in patient care. It also helps reduce complications that lead to unnecessary procedures and the replacement of IV lines, said BD.